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Summary.-y-irradiated rat hepatoma cells are immunogenic in syngeneic WAB/
Not rats, so that immunized animals are protected against tumour-cell challenge
and circulating tumour-specific antibody is produced. Treatment of the immunizing
cells with glutaraldehyde at concentrations of0.0010% or greater for 30 min rendered
these cells non-protective in tumour-rejection tests and no longer able to induce
significant formation of specific antibody. However, tumour-specific antigens were
shown to be expressed upon treated cells; they specifically bound tumour-specific
antibody from syngeneic immune sera assessed in indirect membrane-immuno-
fluorescence tests. Also, these cells specifically absorbed antibody from immune or
tumour-bearer sera, as demonstrated in the indirect membrane-immunofluores-
cence test or a complement-dependent 51Cr-release test. Alloantigen expression was
not influenced by glutaraldehyde treatment, although glutaraldehyde-treated
hepatoma cells failed to induce alloantibody formation in KX/Not rats. Polyacryl-
amide-gel electrophoresis of treated cells, surface-labelled with 1251, indicated that
extensive cross-linking of the surface protein occurred as a result of glutaraldehyde
treatment.
The present findings establish that although the expression of a tumour-specific
antigen is necessary for the induction of immuno-protection against tumour-cell
challenge, this alone is not a sufficient condition for eliciting tumour immunity.
THE ATTENUATION of tumour cells by
chemical treatment before using them as
immunogens has been considered attrac-
tive from several viewpoints (Prager &
Baechtel, 1973; Sanderson & Frost, 1974;
Staab & Anderer, 1977), particularly
since previous studies have indicated that
immunization with chemically modified
antigens, such as flagellin, results in en-
hanced cell-mediated immunity and de-
pressed antibody responses (e.g. Parish &
Liew, 1972). Chemical modification may
be performed with a high degree of repro-
ducibility, and it is possible to ensure that
all cells are rendered inviable. It may be
further argued that, by presenting an
animal with a chemically attenuated
tumour cell, the reactivity against tumour-
associated antigens may be enhanced by
responses against new determinants intro-
duced by the chemical modification. In-
deed, this notion has been supported by
experimental evidence ever since Land-
steiner (1945) demonstrated that anti-
bodies induced by immunization with con-
jugated protein had a broad range of
specificities. These were determined to
be directed against (a) the conjugated
group or hapten, (b) determinants of the
carrier protein and (c) new determinants
composed of the hapten and a portion of
the carrier. Other mechanisms have been
proposed by which chemical modification
may enhance immunogenicity, but with-
out invoking the requisite of the intro-
duction of new groups (Mitchison, 1]970).
In the present studies, the effects of
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surface of an aminoazodye-induced rat
hepatoma (D23) have been investigated.
This tumour is characterized by the ex-
pression of a tumour-specific rejection
antigen against which it is possible to
induce moderate levels of immunopro-
tection when y-irradiated tumour cells are
used as immunogen (Baldwin & Barker,
1967a; Price et al., 1978). Subeellular pre-
parations or soluble antigen isolated from
this hepatoma are generally ineffective in
inducing resistance to tumour challenge
except when administered within a re-
stricted dose range (Price & Baldwin,
1974; Price et al., 1978). The initial
hypothesis considered was to explore
whether stabilization of the cell surface
with glutaraldehyde as a cross-linking
reagent increased or modified the im-
munogenicity of the tumour, the view
being that such treated cells would repre-
sent a more persistent immunogen. For
this purpose, y-irradiated hepatoma cells
as an immunogen of defined efficacy were
treated with glutaraldehyde at various
concentrations and their immunogenicity
and expression of surface antigens were
evaluated.
MATERIALS AND METHODS
Animals, tumours and sera.-Inbred WAB/
Not (Nottingham Cancer Research Campaign
Laboratory subline of WAB) and KX/Not
(Nottingham Cancer Research Campaign
Laboratory subline of KX) rats were main-
tained by single-line brother-sister mating.
Hepatomas D23 and D30, induced by oral
administration of 4-dimethylaminoazoben-
zene, were maintained by serial s.c. passage
in WAB/Not rats. Hepatoma D23- and D30-
bearer sera were from donors bearing i.p.
9-day implants established by injection of
tumour mince (Price & Baldwin, 1977).
Hepatoma D23- and D30-immune sera were
prepared in syngeneic rats by implantation
of y-irradiated (15,000R) grafts of tumour. A
KX/Not anti-WAB/Not alloantiserum was
prepared by s.c. implantation of hepatoma
D23 grafts in male KX/Not rats. Serum
donors were bled by cardiac puncture under
ether anaesthesia, and the serum was col-
lected and stored at -20°C.
Irradiation of hepatoma D23 cells.-Single-
cell suspensions of hepatoma D23 were pre-
pared by trypsinization of tumour mince and
suspended in Hanks' balanced salt solution
(HBSS) (Baldwin & Barker, 1967b). Tumour
cells were attenuated by 60Co y-irradiation
(15,000 R).
Glutaraldehyde treatment ofhepatoma cells.-
Cells suspended in HBSS at 107 cells/ml
were diluted with an equal volume of appro-
priatelydilutedglutaraldehyde (Sigma Chemi-
cal Co., Kingston upon Thames, England)
in phosphate-buffered saline, pH 7-3 (PBS).
After incubation at room temperature for
30 min, treated cells were sedimented and
washed twice with HBSS. In in vitro tests,
treated cells were resuspended in Eagle's
minimal essential medium (MEM) +5%
foetal calf serum (FCS) and incubated for at
least 30 min before use.
Indirect membrane-immunofluorescence test.
-This was performed using viable tumour
target cells in suspension as previously
described (Baldwin & Barker, 1967b). A
fluorescence index was calculated for test
sera by determining the percentage of cells
unstained by normal rat serum minus the
percentage of cells unstained by the test
serum, divided by the former figure, and
values of 0-3 or greater were taken to repre-
sent a significant membrane immunofluores-
cence staining reaction (Baldwin & Barker,
1967b).
Radioisotopic antiglobulin test.-A test was
developed to reveal cell-bound, rat alloanti-
body, using a radioiodinated F(ab')2 frag-
ment ofthe antibody fraction isolated from a
sheep anti-rat IgG antiserum. Briefly, this
latter reagent was prepared by ammonium
sulphate (33% saturated) precipitation ofthe
Ig fraction from the sheep anti-rat IgG
serum followed by pepsin digestion of this
fraction (enzyme: substrate, 1: 100 in Wal-
pole's acetate buffer, pH 4 5, for 16 h;
Stanworth & Turner, 1973). F(ab')2 frag-
ments were then separated by Sephadex
G200 column chromatography eluted by up-
ward flow with PBS. The F(ab')2 antibody
was then isolated by immunoadsorption to
rat IgG convalently linked to CNBr-activated
Sepharose 4B (Pharmacia Ltd, Uppsala,
Sweden). Bound material was eluted with
50mm glycine-HCl, pH 2-8, and passed
directly over Sephadex G25 to desalt the
eluate rapidly. This F(ab')2 antibody pre-
paration was iodinated with Na125J (Radio-
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chemical Centre, Amersham, Bucks) using a
modified chloramine-T method (McConahey
& Dixon, 1966) to give a specific activity of
0415 ,uCi/,ug protein
For the isotopic antiglobulin assay, hepat-
oma D23 cells were seeded into the wells of
plastic microtitre plates (Cooke M29 ART)
at 104/well, and the plates were incubated at
37°C overnight to allow cell adherence.
After washing the plates by immersion and
gentle agitation in 3 separate baths of PBS,
cells were pretreated with PBS or 0.01%
glutaraldehyde for 30 min at room tem-
perature. The plates were then washed in 3
separate baths of PBS. The contents of each
well were then aspirated to leave 90 pu PBS;
lO,ul FCS was added to each well, and incu-
bated at room temperature for 30 min.
Aliquots (0-1 ml) of diluted sera were added
to each well and, after incubation at 37°C for
30 min, plates were washed in PBS. Aliquots
(0.1 ml) of 1251-F(ab')2 of the antibody
fraction of the sheep anti-rat IgG serum (at
106 ct/min/ml) were added to each well and,
after incubation at 37°C for 30 min, plates
were washed again 4 times with PBS and then
air dried. Adherent cells were fixed with
Nobecutane aerosol spray (Astra Chemicals
Ltd, Watford, England) and individual wells
were cut out with a band saw and counted
for radioactivity. All PBS solutions used in
this assay contained 1-0 mm Ca++ and
0 5 mm Mg++.
5IChromiumn-release test.-This was per-
formed according to a previously described
microassay procedure (Price, 1978).
125I-Labelling of cells.-Hepatoma cell
surfaces were radioiodinated according to the
method of Phillips & Morrison (1971).
Briefly, 200 ,tCi Na125J was added to glutaral-
dehyde-treated or untreated hepatoma cells
(1 ml at 107 cells/ml in PBS). To this 50 ,ug
lactoperoxidase (Sigma Chemical Co., King-
ston upon Thames, England) and 25 ,ul of
0-03% H202 in PBS was added. The cells
were kept at room temperature for 10 min
and a further 25 ,ul of 0-03% H202 was
added. After 10 min, the cells were diluted to
25 ml with PBS and washed x4 by centri-
fugation with PBS. The final pellet was sus-
pended in 4 ml of 2% sodium dodecyl sul-
phate (SDS) containing 2% /3-mercapto-
ethanol, which was heated to 100°C for 5 min.
The resulting solution was dialysed against
0.1% SDS, 0.1% 3-mercaptoethanol in
OO1m sodium phosphate buffer, pH 7-0, for
18 h. Aliquots of the SDS-solubilized cells
were separated by analytical polyacrylamide-
gel electrophoresis upon 10% acrylamide gels
according to the method of Weber & Osborn
(1969). Gels were cut into 2 mm slices which
were individually counted in an LKB-
Wallac Gamma Counter.
RESULTS
In a preliminary experiment, the dose
and timing of i.p. immunization with
y-irradiated hepatoma D23 cells was in-
vestigated. As shown in Table I, treat-
ment of rats with a single injection of 106
immunizing cells from between 28 days
before s.c. tumour-cell challenge and 7
days after challenge was ineffective in
modifying the incidence of tumours.
Immunization with 107 irradiated cells at
7 and 14 days before challenge provided
protection against tumour growth and,
using the highest immunizing dose of 108
cells, resistance against challenge was
evident in all groups of rats receiving
immunization up to 28 days before
challenge. In no case was it possible sig-
nificantly to modify the incidence of
tumours when treatment was given after
tumour-cell challenge (Table I).
In subsequent experiments, when glut-
araldehyde y-irradiated cells were used as
theimmunogen, asingledoseof ' 2-5 x 107
cells was given 7 days before s.c. tumour-
cell challenge with between 1 x 103 and
TABLE I.-I.p. immunization with y-
irradiated hepatoma D23 cells-effect of
dose and timing
Day of immunization
before s.c. challenge
with 2 x 103 D23 cells
28
21
14
7
3
0
-3
-7
Tumour takes in 6 rats
immunized* with
(no. of y-IR D23 cells)
106 107 108
6
6
5
3
5
6
5
5
5 3
3 0
1 1
1 0
2 1
3 2
6 6
6 5
* Tumour takes in untreated, age-matched con-
trols=22/24.
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5 X 103 viable D23 cells. These conditions
were considered suitable for revealing
modification of immunoprotection in rats
receiving the chemically modified im-
munogen.
TABLE II.-Immunization with glutaral-
dehyde, y-irradiated hepatoma D23 cells
Immunization*
None
y-irradiated D23 cells (2-5 x 107)
pretreated witht:
PBS
0-00001% Glutaraldehyde
0-00010% Glutaraldehyde
0-001% Glutaraldehyde
0-01% Glutaraldehyde
0-10% Glutaraldehyde
0.5% Glutaraldehyde
2-5% Glutaraldehyde
Tumour incidence
in rats challenged
witht:
5X 1032x 1031x 103
cells cells cells
5/5 6/6 10/12
1/5
NT§
NT
NT
5/5
5/5
5/5
5/5
1/7
NT
2/6
6/6
6/6
6/6
NT
NT
2/12
2/6
1/12
3/12
8/12
10/12
NT
NT
* y-irradiated (15,000 rad) hepatoma D23 cells
were injected i.p. 7 days before tumour-cell chal-
lenge.
§ Challenged by s.c. injection of tumour cells in
0-2 ml aliquots.
I y-irradiated cells were pretreated for 30 min
with glutaraldehyde or, in controls, PBS at room
temperature, and they were washed twice by centri-
fugation with HBSS before injection.
§ NT Not tested.
Table II shows the results of 3 experi-
ments in which the effect of treating
y-irradiated D23 cells with glutaraldehyde
was analysed by determining their capa-
city to induce immunoprotection against
a challenge with D23 cells. It is evident
that in rats receiving D23 cells treated
with glutaraldehyde at concentrations as
low as 0.01% (and in one case 0-001%),
the tumour incidence was essentially the
same as that in untreated control animals.
This contrasts with the result ofimmuniz-
ing rats with y-irradiated hepatoma cells
treated with either PBS or with glutar-
aldehyde at concentrations lower than
0.001%, when a reduced tumour incidence
was apparent.
The humoral response to immunization
withglutaraldehyde-treated anduntreated
y-irradiated D23 cells, as assessed by the
indirect membrane-immunofluorescence
test, is shown in Table III. The only group
of rats exhibiting a significant membrane-
immunofluorescence reaction with sera,
giving a fluorescence index >03, was the
group immunized by 4 weekly i.p. injec-
tions of untreated, y-irradiated D23 cells
(Group 2, Table III). The capacity of
these cells to induce specific antibody pro-
duction was abolished by pretreatment
with glutaraldehyde at concentrations of
0-001 and 0-01% (Groups 3 and 4, respec-
tively; Table III).
Although these results suggest that the
activity of the tumour-specific antigen
associated with D23 is lost or significantly
diminished when assayed by the induction
of immune responses, the results in Table
IV indicate that glutaraldehyde-treated
y-irradiated D23 cells still retain a sero-
logically identifiable tumour-specific anti-
gen when assessed in membrane-immuno-
fluorescence tests. In these experiments,
D23 immune or bearer serum (containing
antibody specifically reactive with D23
cells (Baldwin & Barker, 1967a; Price &
Baldwin, 1977) reacted positively with
y-irradiated D23 cells, giving fluorescence
TABLE III.-Humoral response to immunization with glutaraldehyde-treated 'y-irradiated
D23 cells
Group Immunization procedure* % Glutaraldehydet
1 I ml HBSS x 4
2 107 y-irradiated D23 cells x 4
3 107 y-irradiated D23 cells x 4 0-001
4 107 y-irradiated D23 cells x 4 0-01
Fluorescence index)
(mean± s.d.)
0-04+0-03
0-48±0-11
0-11 +0-16
0-08±0-11
* Immunizing y-irradiated (15,000 rad) D23 cells were injected i.p. at weekly intervals. Rats were bled
7 days after the final injection.
t Cells were pretreated for 30 min with glutaraldehyd3 or, in controls, with PBS at room temperature and
washed twice by centrifugation with HBSS before injection.
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TABLE IV.-Membrane-immunoftuorescence reactions withglutaraldehyde-treated
y-irradiated D23 cells
Fluorescence indices (mean±s.d.) with
y-irradiated D23 cells pretreated* with
glutaraldehyde at a concentration of:
Serum
Normal WAB/Not serum
D23 IR graft-immune
D30 IR graft-immune
D23-bearer serum
D30-bearer serum
KX/Not anti-WAB/Not alloantiserum
* For 30 min at room temperature.
0%
0-49+0-06
0-03±0-00
0-57±0-06
0-06±0-05
1-00±0-00
0-001%
0-02±0-03
0-54
0-14
0-55+0-05
0-05±0-02
1-00±0-00
0-01%
0-09±0-06
0-54±0-05
0-16±0-08
0-61 +0-05
0-09±0-06
1-00±0-00
TABLE V.-Absorption of anti-D23 antibody by glutaraldehyde-treated cells: membrane
immunoftuorescence tests
Absorption conditions*
Absorbing No. cells/ml
Expt. tumour serum (107)
1
D23 2
2
5
5
2
2
5
5
D30
2
D23 2
2
5
5
2
2
5
5
D30
% Glutar- Fluorescence index
aldehydet (mean±s.d.)
- 0-55±0-06
- 0-14+0-07
0-01 0-14±0-07
0-05±0-05
0-01 0-00+0-05
0-42
0-01 0-49
0-46
0-01 0-46
0-64±0-04
- 0-14±0-09
0-5 0-29±0-06
0-07±0-06
0-05 0-13±0-08
0-59+0-04
0-5 0-57±004
- 0-56±0 09
0-5 0-56±0-07
* At 4°C for 2 h.
t Pretreatment for 30 min at room temperature.
TABLE VI.-Absorption of anti-D23 antibody by glutaraldehyde-treated cells: complement-
dependent cytotoxicity test
Absorption conditions*
C-
No. cells/ml
Absorbing tumour serum (107)
D23
D30
2
2
5
5
2
2
5
5
% Glutaraldehydet
0-5
0-5
0-5
0-5
% Cytotoxicity after
2h 4h
40-2 (3-0)t 46-2 (1-9)
4-7 (0 7) 6-3 (-0 2)
6-3 (-0 6) 8-3 (4-0)
4-7 (-1-5) 7.9 (-0-4)
6-3 (-0 6) 8-1 (1-0)
38-1 (0 9) 42-3 (1-8)
35-4 (1-2) 38-9 (1-1)
37-1 (0 8) 40-1 (2-5)
32-1 (0 4) 38-9 (-1-3)
* At 4°C for 2 h.
t Pretreatment for 30 min at room temperature.
: In parentheses, the % cytotoxicity in samples to which heat-inactivated complement (56°C for 60 min)
was added.
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indices of >0 3, and these reactions were
demonstrable using glutaraldehyde-treat-
ed as well as untreated tumour target
cells. Conversely, sera from rats sensitized
to hepatoma D30 (i.e. from donors
immunized against, or bearing this
tumour) failed to react with treated or
untreated D23 target cells (Table IV).
That glutaraldehyde failed to modify
the reactivity of D23-specific antigen in
in vitro tests is further confirmed in
Tables V and VI. These tests showed that
absorption of sera containing specific
antibody to D23 with glutaraldehyde-
treated and untreated D23 cells removed
their reactivity for D23 target cells, as
assessed by the indirect membrane-
immunofluorescence test (Table V) and
by complement-dependent cytotoxicity
assays using a 51Cr-release test (Table VI).
Exposure of cells to concentrations of
glutaraldehyde as high as 0-5% did not
modify their capacity to remove tumour-
specific antibodies. However, when these
sera were absorbed with treated or un-
treated D30 cells, their reactivities for
D23 cells by immunofluorescence (Table
V) or complement-dependent cytotoxicity
(Table VI) were equal, and in all cases
comparable to those of unabsorbed
sera.
It is clear from the data in Table IV
that KX/Not anti-WAB/Not alloantigens
associated with D23 were largely un-
affected bytreatment withglutaraldehyde,
since this alloantiserum reacted strongly
with treated and untreated target cells,
giving in all instances a fluorescence index
of 10. This conclusion was substantiated
by a more quantitative radioisotopic anti-
globulin assay using an 1251-labelled
F(ab')2 fragment of the antibody from a
sheep anti-rat IgG serum to reveal cell-
surface-bound rat immunoglobulin on
D23 cells. As shown in Table VII, the
uptake of the antiglobulin reagent was
essentially equal with both untreated D23
cells and with D23 cells treated with 04 %
glutaraldehyde, which had been exposed
to normal or alloantiserum at dilutions of
1/100, 1/500 and 1/1000. At each of these
dilutions the uptake of radiolabel in cells
exposed to alloantiserum was considerably
greater than in cells exposed to normal
serum at the same dilution, or medium
alone (Table VII). Although KX/Not
anti-WAB/Not alloantigens were still ex-
pressed on D23 cells treated with glutaral-
dehyde, these cells did not induce allo-
antibody formation in KX/Not rats as
assayed by either the indirect membrane-
immunofluorescence test of the radio-
isotopic antiglobulin assay. As shown in
Table VIII, serum from KX/Not rats
immunized by 4 injections of 107 y-
irradiated D23 cells (Group 2) showed
positive membrane-immunofluorescence
staining of D23 cells (fluorescence index,
1P0±0 00), whereas sera from rats im-
munized with glutaraldehyde-treated D23
cells (Group 3) displayed equal reactivity
to the serum from medium-treated donors
TABLE VII.-Radioisotopic antiqlobulin testfor the detection ofKX/Not alloanti-WAB/Not
antibodies bound to glutaraldehyde-treated D23 cells
Serum
Medium
Normal KX/Not serum
KX/Not anti-WAB/Not alloantiserum
Uptake of 1251-F(ab')2 antibody of
sheep anti-rat IgG serum to:
D23 cells pretreated* with
Dilution Untreated D23 cells 0 01% glutaraldehyde
19±10t (49±7) 0±6 (57±6)
1/100 57±59 (54±10) 7±11 (96±13)
1/500 17±8 (47±6) 3±1 (60±6)
1/1000 10±1 (56+3) 8±11 (53±4)
1/100 1141±13 (107+18) 1175+27 (134+4)
1/500 575±129 (60±1) 443±107 (80±22)
1/1000 267±10 (62±3) 225±15 (55±13)
* For 30 min at room temperature.
t Mean ct/min±s.d. after subtraction of values in wells without added cells (the values in parentheses).
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TABLE TIII.-Induction of KX/Not anti-D23 alloantibody by immunization with
glutaraldehyde-treated y-irradiated D23 cells
Radioisotopic antiglobulin test
t --_
Grouip Immunizationi procedure*
1 lmlHBSSx4
2 107 y-irradliated D23 cells/
PBS x 4
3 107 y-irradliatedl D 23 cells/
0.01 % gltutaraldlehydle x 4
Serum
(lilution
1/20
1/200
1/1000
1/20
1/200
1/1000
1/20
1/200
1/1000
Uptake of '25J-F(ab')2
antibody ofsheep
anti-rat IgG seruimt
606± 177
110± 126
132± 44
4612 ± 1434
1452±655
423± 105
465± 194
227 ± 73
162± 65
Membrane-
I immunofluorescence test
Fluorescence index
(mean ±s.d.)
-0-02±0-02
1-00±0-00
0 03±0 05
* Imnmunizing, y-iiiadliate(l D23 cells were injected i.p. into groups of 3 rats, x 4 at weekly intervals. Rats
bled 7 (lays after the final injection. y-irradiated cells wvere pretreated for 30 min with glutaraldehydle, or in
controls, PBS, at room temperature and then washed twice by centrifugation with HBSS before injection.
t M\ean ct/mini s.d. after subtraction of values obtaine(d fo rwells without added cells.
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Finally, the effect of glutaraldehyde
treatment of y-irradiated D23 cells was
analysed by gel electrophoresis after
lactoperoxidase-catalysed radioiodination
of treated cell surfaces. D23 cells, treated
either with PBS alone or 0.01% or 0.5%0
glutaraldehyde, were solubilized by boiling
in 20% SDS for 5 min and samples were
applied to 100% polyacrylamide gels. The
Figure shows the separation achieved,
and 2 major features are evident. Firstly,
with increased glutaraldehyde concentra-
30 35 40 tion, more of the labelled material failed
to enter the gel, remaining on the top. elect,ro- Secondly, a similar distribution of labelled
)rot!eins of *_ ) proteins was found in each of the gels,
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,lobulin test glutaraldehyde fixation of tumour-cell
ly serum to surfaces renders these cells no longer
ret cells at effective in eliciting immunity to tumour-
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cell challenge, or able to induce tumour-
specific or alloantibody formation. How-
ever, glutaraldehyde treatment did not
apparently modify the ability of these
cells to bind either tumour-specific anti-
body from syngeneic immune sera or KX/
Not anti-hepatoma D23 alloantibody, in-
dicating that these antigens associated
with this hepatoma were not inactivated.
These observations may have several
interpretations, and are highly relevant to
defining the parameters requisite for the
full expression ofimmunogenicity. Firstly,
it may be argued that the serologically
defined tumour-specific antigen associated
with hepatoma D23 may be different from
the determinant eliciting immunity (the
latter being labile to glutaraldehyde).
This would seem unlikely, since close
correlation has been found between the
expression and specificity of rejection
antigens and antigens identified by
humoral and cell-mediated immune assays
(reviewed in Baldwin, 1973; Baldwin &
Price, 1975) although formal proof of this
point is not available. Alternatively,
although the presence of a tumour-
specific antigen at the cell surface may be
necessary for the induction of immunity,
that in itself may not be sufficient.
Similar proposals have been reported from
studies on murine alloantigens, showing
that whilst mild treatment with glutaral-
dehyde did not markedly alter the anti-
genicity of P815 murine mastocytoma
cells, the immunogenicity of these cells
was lost (Bubbers & Henney, 1975). Thus,
treated cells failed to induce blastogenesis
of co-cultivated allogeneic lymphocytes,
and cytolytically active cells did not
develop in these cultures.
In another investigation, Forman (1977)
was able to define the conditions for
glutaraldehyde treatment under which
treated cells stimulated cell-mediated
lympholysis but not mixed-lymphocyte
reactivity, demonstrating that the 2
phenomena can be dissociated.
If, as seems likely, the induction of
cytotoxic T cells is important for the
establishment of tumour immu-inity (Bald-
win, 1978), it may be relevant to consider
the possibility that the tumour-specific
antigens on glutaraldehyde-treated hepat-
oma cells are no longer immunogenic
because they are unable to generate these
effector cells. Indeed, Dennert (1974) has
found that glutaraldehyde-treated P815
mastocytoma cells, whilst unable to gener-
ate cytotoxic T cells in vivo, do give rise to
T helper cells. Thus, spleen cells from
allogenic C57BL/6 mice immunized with
fixed P815 cells displayed no cytotoxicity
towards homologous target cells, but
formed antitrinitrophenol antibody tn
vitro when incubated with trinitrophenyl-
ated P815 cells.
One important factor influiencing the
immunogenicity of living allogeneic cells
has been shown to be the metabolic state
of the cells. Indeed, for the in vitro induc-
tion of cell-mediated cytolysis an active
cell metabolism was required, one inter-
pretation being that protein turnover at
the cell surface was necessary for the full
expression of immunogenicity (Wagner,
1973). To what extent the irradiated
hepatoma cells used in the present studies
retain an active cell metabolism, albeit for
a limited period, is the subject of a later
report (Dennick et al., 1979). The effects of
glutaraldehyde on cell metabolism are
profound, and in one study it was found
that treatment with 0 1500 glutaraldehyde
for only 10 s destroyed cells' ability to
incorporate amino acids or nucleotides
into macromolecules (Bubbers & Henney,
1975). Certainly the conditions used in the
present investigation, involving treatment
for 30 min, would be sufficient to modify
the efficiency of the cell's synthetic appar-
atus. Indeed, the conditions of treatment
were sufficient to markedly cross-link
much of the surface protein, as demon-
strated by the polyacrylamide-gel electro-
phoresis ofradioiodinated, glutaraldehyde-
treated hepatoma cells (Fig. 1). In these
tests, with increasing glutaraldehyde con-
centrations, more of the labelled material
was covalently linked into insoluble high-
mol.-wt aggregates which failed to enter
the polvaervlamide gel. However, whether
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there is any parallel between the extent of
cross-linking andthereductioninimmuno-
genicity remains to be seen. Also, with
other tumour models it has been possible
to use various chemical treatments, in-
cluding the use of cross-linking reagents,
for the attenuation of viable tumour cells
with retention of demonstrable levels of
immunogenicity (Prager & Baechtel,
1973).
Finally, while the glutaraldehyde-fixed
cell (expressing the tumour-specific anti-
gen on an essentially inert carrier) may
represent a more persistent immunogen,
such material may not however be access-
ible to effective macrophage processing.
The processing of different materials such
as soluble and particulate antigens is
known to differ (Unanue, 1972) and if
macrophage degradation of multidetermi-
nant cellular antigen is necessary for the
induction of immunity (Brunda & Raffel,
1977) clearly the fixed cell as an immuno-
gen would be far less amenable to these
processes than the unfixed cell.
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